RAC 0.97% $1.54 race oncology ltd

ASH2023 - Sheba 2.0, page-31

  1. 211 Posts.
    lightbulb Created with Sketch. 461
    A phenomenal result on so many fronts.

    It's easy to get swept away in negativity, which tends to make us doubt even the most irrefutable of facts regarding the known benefits of Bisantrene.

    This is exactly the "punch in the face" moment that many investors look for in order to jump on board. Luckily, I've already loaded up and won't need to chase the price up to get my fill, like many will inevitably have to do after these outstanding results.

    And last but not least, we've all lost loved ones to cancer, and the joys of realizing the life-saving potential of Bisantrene will surely supersede the joy of the profits we will hopefully make on it.



 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.